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Background:High-sensitivity C-reactive protein (hsCRP) has been shown to predict cardio-
vascular disease (CVD) endpoints and is associated with CVD risk factors and the metabolic
syndrome. This study evaluated the association between hsCRP and CVD risk factors
among Afro-Caribbean young adults in Jamaica.
Methods: We conducted a cross-sectional analysis of data from the Jamaica 1986 Birth
Cohort Study. Data were collected between 2005 and 2007 when participants were 18–
20 years old. All participants completed an interviewer administered questionnaire and had
anthropometric and blood pressure (BP) measurements performed. Fasting blood samples
were collected for measurement of glucose, lipids, and hsCRP. Logistic regression models
were used to identify factors independently associated with high hsCRP.
Results: Analyses included 342 men and 404 women with mean age 18.8±0.6 years.
Approximately 15% of the participants had high risk hsCRP (>3 mg/L), with a higher preva-
lence among women (20 vs. 9%; p<0.001). The prevalence of elevated hsCRP increased
with body mass index category, high waist circumference (WC), high triglycerides, low high
density lipoprotein, and lower parental education among women, but only for high WC and
lower parental education among men. In logistic regression models controlling for sex and
parental education, high WC was associated with significantly higher odds of high hsCRP
(OR 7.8, 95% CI 4.8–12.9, p<0.001). In a similar model, high hsCRP was also associated
with the number of metabolic syndrome components. Compared to participants with no
metabolic syndrome component, having one metabolic syndrome component was associ-
ated with a twofold higher odds of high hsCRP (OR 2.2, 95% CI 1.3–3.8, p=0.005), while
having three components was associated with a 14-fold higher odds of high hsCRP (OR
13.5, 95% CI 2.4–76.0, p<0.001).
Conclusion: High hsCRP is common among Jamaican young adults and is strongly
associated with central obesity and the number of metabolic syndrome components.
Keywords: high-sensitivity C-reactive protein, cardiovascular disease,metabolic syndrome, young adults, Jamaica,
Caribbean, Black
INTRODUCTION
Almost 50% of persons with acute myocardial infarction in the
USA have no overt evidence of hyperlipidemia, and 15–20% have
none of the traditional cardiovascular disease (CVD) risk factors
(1, 2). As a result, there has been considerable interest in identify-
ing risk markers that will refine and improve the clinician’s ability
to predict CVD (3). Inflammation is now regarded as one factor
that might explain this phenomenon. It is generally accepted that
inflammation plays an active role in the pathogenesis of CVD and
is a possible trigger of CVD events (4, 5). Several clinical stud-
ies have demonstrated that chronic inflammation is a predictor
of future CVD events and that biomarkers of inflammation can
improve risk prediction in CVD (4–6). In adults, inflammation is
an independent risk factor for both the metabolic syndrome and
CVD (7, 8).
One increasingly popular marker of inflammation is C-reactive
protein (CRP), an acute phase protein, which is markedly elevated
in inflammatory conditions such as infections, and is also elevated
in CVD, but in much lower concentrations (9–12). The develop-
ment of assays capable of measuring mild elevation of CRP, termed
high-sensitivity C-reactive protein (hsCRP), resulted in the wide-
scale use of this biomarker in the evaluation of CVD risk (10).
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High-sensitivity CRP has been shown to predict the risk of CVD
endpoints such as myocardial infarction, stroke, and CVD death
independent of other traditional risk factors for CVD (2, 4, 5).
In addition, some studies have shown associations between high
hsCRP and socioeconomic status (SES) (13–15).
Most studies of the relationship between hsCRP and CVD have
been done in middle-aged or older persons; however, associa-
tions between hsCRP and CVD risk factors among adolescents and
young adults have been reported in a few studies (16–18). In chil-
dren and adolescents, even low-grade systemic inflammation has
been shown to be associated with the metabolic syndrome (19, 20).
To our knowledge, no study has evaluated the associations between
hsCRP and CVD risk in young adults from the Caribbean, where
a high burden of CVD risk factors have been demonstrated (21).
We therefore sought to evaluate the relationship between hsCRP
levels and CVD risk factors among participants of the Jamaica
1986 Birth Cohort Study. We chose hsCRP as the inflammatory
biomarker because of the large body of data supporting its use-
fulness as a marker of CVD risk and because laboratory assays are
available for its use in current clinical practice.
We hypothesized that high hsCRP levels are associated with
individual CVD risk factors and with clustering of CVD risk factors
as seen in the metabolic syndrome. Specifically, we aimed to (1)
estimate the proportion of persons with high risk hsCRP; (2) eval-
uate the relationship between elevated hsCRP and traditional CVD
risk factors [blood pressure (BP), glucose, obesity, dyslipidemia];
and (3) evaluate whether elevated hsCRP is associated with the
clustering of multiple CVD risk factors expressed as the number
of metabolic syndrome components. We also explored whether
high hsCRP was associated with SES (using parental education
level).
MATERIALS AND METHODS
STUDY DESIGN
This study was a cross-sectional analysis from the Jamaica 1986
Birth Cohort Study (22). Details of the study design, follow up,
and recruitment procedures have been previously published (22,
23). In the third follow up round of the cohort, 902 participants,
aged 18–20 years were seen between March 2005 and February
2007. The study was approved by the University of the West Indies,
Faculty of Medical Sciences Ethics Committee, and all participants
provided written informed consent prior to evaluation.
MEASUREMENTS AND DEFINITIONS
Trained research nurses administered questionnaires during face
to face interviews in order to obtain data on personal and family
medical history, SES, and physical activity levels. The nurses also
obtained BP and anthropometric measurement (weight, height,
waist, and hip circumference) using standard techniques. A fasting
blood sample was collected for glucose, lipid levels, and hsCRP.
Blood pressure was measured using a mercury sphygmo-
manometer following standardized procedures developed for the
International Collaborative Study of Hypertension in Blacks (24).
Waist circumference (WC) was measured using a non-stretchable
nylon tape. Height was measured using a portable stadiometer and
weight was measured using a portable digital scale. Elevated BP was
defined as systolic BP ≥120 mmHg or diastolic BP ≥80 mmHg,
incorporating the prehypertension and hypertension categories,
as defined by the Seventh Report of the Joint National Com-
mittee on Prevention, Detection, Evaluation, and Treatment of
High BP (JNC 7) (25). Body mass index (BMI) was calculated as
weight in kilograms divided by the square of height in meters and
the World Health Organization classification used to define over-
weight as BMI of 25.0–29.99 and obesity as BMI≥30.0 kg/m2 (26).
Central obesity, high fasting glucose, high triglycerides, and low
high density lipoprotein (HDL) cholesterol were defined using the
metabolic syndrome cut points recommended by the 2009 Con-
sensus Criteria by the International Diabetes Federation,American
Heart Association, and others (27). The specific cut points were:
central obesity≥94 cm for men and≥80 cm for women; high fast-
ing glucose, ≥5.6 mmol/L; high triglycerides, ≥1.7 mmol/L; low
HDL<1.0 mmol/L in men and<1.3 mmol/L in women. For meta-
bolic syndrome categorization, high BP was determined using cut
points of ≥130 mmHg for systolic BP and ≥85 mmHg (27). Par-
ticipants with any three of the five components were classified as
having the metabolic syndrome as defined by the 2009 Consen-
sus Criteria (27). High total cholesterol was defined as cholesterol
≥5.2 mmol/L and increased low density lipoprotein cholesterol
(LDL) was defined as LDL ≥4.1 mmol/L in accordance with the
recommendations from National Cholesterol Education Program
Adult Treatment panel III criteria (ATP III) Expert Panel (28).
High-sensitivity CRP was measured from stored serum sam-
ples using the IMMULITE® 1000 High-Sensitivity CRP enzyme
immunoassay test kits (Siemens Medical Solution Diagnostics,
Los Angeles CA, USA). Tests were performed in duplicate by a
single laboratory technician using standard quality control proce-
dures to ensure validity and reliability of test results. The test has
an analytic reportable range of 0.3–100 mg/L. Where participants
had values below the reference range, they were assigned a value
of 0.3 mg/L. For analysis, the mean of the two values were used.
Risk categories recommended by the American Heart Association
and Center for Disease Control were used to categorize hsCRP
as low risk (hsCRP <1 mg/L), moderate risk (hsCRP 1–3 mg/L)
and high risk (hsCRP >3 mg/L) (8). For outcome analyses, we
defined high hsCRP as hsCRP >3 mg/L. Participants with hsCRP
>10 mg/L were excluded from the analyses as these levels may
reflect infection or inflammatory disorder (8).
Socioeconomic status was defined as the highest level of edu-
cation attained by either parent or guardian and categorized as:
primary/all age, secondary, or tertiary. Persons who responded
“do not know” to the questions on education of parents/guardian
were treated as a fourth category. Leisure time physical activity lev-
els were defined based on time spent playing sports or engaged in
exercise (e.g., brisk walking). Participants who reported no leisure
time physical activity were classified as having low physical activ-
ity level, participants reporting 3.5 h or less of physical activity per
week as moderate of physical activity level, while those reporting
more than 3.5 h of physical activity per week were classified as high
physical activity level.
STATISTICAL ANALYSIS
Data were analyzed using Stata 12.1 (Stata Corp., College Station,
TX, USA). Descriptive analyses included means and proportions
for outcome and explanatory variables as appropriate. Where data
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were highly skewed, we reported medians and interquartile range.
Means were compared using the t -test while difference in pro-
portions were compared using the Pearson’s chi-squared test. For
comparison of means across multiple categories, we used one-way
analysis of variance or the Kruskal–Wallis test if there was evidence
on unequal variance across the categories. As there was evidence
of sex interaction in the relationship between some CVD risk fac-
tors and high hsCRP, we present sex-specific estimates for bivariate
analyses. Logistic regression was used to identify factors indepen-
dently associated with high hsCRP. All variables, which showed
evidence of association (p< 0.05) in the bivariate analyses and
those with an a priori hypothesized association, were sequentially
added to the model and the likelihood ratio test used to identify
variables, which significantly improved the model.
In order to assess whether hsCRP was associated with clustering
of CVD risk factors, we created a variable based on the number
of metabolic syndrome components present in participants (ele-
vated BP, high fasting glucose, central obesity, low HDL, and high
triglycerides). We then assessed whether the number of risk factors
was significantly associated with high hsCRP.
Since our study tested two primary hypotheses, the significance
level for the final models was adjusted to 0.025 using the Bonfer-
roni method as recommended by Bender and Lange (29) and by
Sedgwick (30).
Data on hsCRP was unavailable for 61 participants and 45 par-
ticipants had hsCRP values >10 mg/L. Another 50 participants
had missing values for at least one additional variable of interest.
The final analysis was therefore limited to 746 participants with
full data for the variables of interest.
RESULTS
Analyses included 342 men (46%) and 404 women (54%) with
mean age 18.8± 0.6 years. Sex-specific characteristics of the study
participants are shown in Table 1. Men had higher systolic BP,
diastolic BP, fasting glucose, and triglycerides whereas women had
higher mean total cholesterol, LDL, HDL, and hsCRP. In order
to assess the potential impact of participants who were excluded
from the analyses, we compared mean values of the characteristic
shown in Table 1 (except for hsCRP) for included and excluded
participants. There were no significant differences for participants
included in the analysis compared to those excluded.
The proportion of participants with individual CVD risk fac-
tors and high hsCRP (>3 mg/L) is shown in the Supplemen-
tary Material (Table S1 in Supplementary Material). Approx-
imately 15% of the participants had high risk hsCRP with
women having a prevalence of 20% compared to 9% among
men (p< 0.001). Approximately 21% of participants had elevated
BP (BP ≥120/80 mmHg), 17% were overweight and another 7%
obese; 14% of participants had high cholesterol and 46% had low
HDL. Prevalence of elevated triglycerides and impaired fasting
glucose was relatively low, 0.5 and 1.1%, respectively; 6% had high
LDL cholesterol. Men were more likely to have elevated BP and
fasting glucose, while women had a higher prevalence of all other
CVD risk factors. High triglyceride was rare in both men and
women.
Table 2 shows the proportion of participants with high hsCRP
(>3 mg/L) by traditional CVD risk factor categories and SES
Table 1 | Summary statistics for participant characteristics by sex.
Characteristic Male
(n=342)
Female
(n=404)
P -value for
male: female
differencesa
Mean±SD Mean± SD
Age 18.8±0.6 18.8±0.6 0.188
Height (cm) 176.8±6.5 163.4±6.2 <0.001
Weight (kg) 70.8±13.9 61.7±14.4 <0.001
BMI (kg/m2) 22.6±4.2 23.1±5.2 0.200
Waist circumference (cm) 75.1±10.9 73.3±11.0 0.033
Systolic BP (mmHg) 114.0±10.7 107.1±8.7 <0.001
Diastolic BP (mmHg) 69.4±10.2 66.9±8.9 <0.001
Glucose (mmol/L) 4.7±0.6 4.4±0.4 <0.001
Total cholesterol (mmol/L) 4.2±0.8 4.5±0.9 <0.001
HDL (mmol/L) 1.1±0.2 1.3±0.3 <0.001
LDL (mmol/L) 2.7±0.7 3.0±0.8 <0.001
Triglycerides (mmol/L) 0.60±0.3 0.55±0.2 0.007
hsCRP (mg/L) 1.1±1.5 1.8±2.1 <0.001
Median (IQR) Median (IQR)
bhsCRP (mg/L) 0.5 (0.9) 1.0 (2.0) <0.001
Number (%) Number (%)
hsCRP risk categories <0.001
Low risk 235 (68.7) 208 (51.5)
Moderate risk 78 (22.8) 114 (28.5)
High risk 29 (8.5) 81 (20.0)
Highest parental SES 0.005
Tertiary education 73 (21.4) 114 (28.2)
Secondary education 179 (52.3) 194 (48.0)
Primary education 32 (9.4) 54 (13.4)
Unknown 58 (17.0) 42 (10.4)
Physical activity levels (PAL) <0.001
High PAL 124 (36.3) 54 (13.4)
Moderate PAL 155 (45.3) 165 (40.8)
Low PAL 63 (18.4) 185 (45.8)
aP-values for means from t-tests comparing males and females while p-values
for difference in proportions are from chi-squared tests again comparing males to
females.
bThe hsCRP distribution was skewed; hence, we also present median and
interquartile range (defined as the difference between the 75th and 25th centiles).
hsCRP, high sensitivity C-reactive protein; SES, socioeconomic status; PAL, phys-
ical activity levels; BMI, body mass index; BP, blood pressure; HDL, high density
lipoprotein cholesterol; LDL, low density lipoprotein cholesterol. Total cholesterol
includes LDL, HDL, and other lipoproteins.
(based on parental education level). Only central obesity and
parental education were significantly associated with high hsCRP
among men, but associations were also seen for BMI, low HDL,
and high triglycerides among women. There was no significant
association between high hsCRP and physical activity level (data
not shown).
We also obtained mean values for CVD risk factors by hsCRP
category for men and women. These data are shown in Table S2
in Supplementary Material. Among men, significant associations
with hsCRP category were seen for BMI and WC only with persons
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Table 2 | Proportion of participants with high risk hsCRP within categories of CVD risk factors and socioeconomic status (parental education
level) for male and female participants.
Variable Male Female
Number in
category
High hsCRP
number (%)
P -value Number in
category
High hsCRP
number (%)
P -valuea
BMI 0.111 <0.001
Underweight 23 1 (4.3) 58 6 (10.3)
Normal weight 255 18 (7.1) 229 27 (11.8)
Overweight 47 4 (8.5) 79 21 (26.6)
Obese 17 6 (35.3) 38 27 (71.1)
Elevated blood pressure 0.486 0.258
No 241 22 (9.1) 351 67 (19.1)
Yes 101 7 (6.9) 53 14 (26.4)
High WC 0.048 <0.001
No 326 24 (7.4) 312 34 (10.9)
Yes 16 5 (31.3) 92 47 (51.1)
High glucoseb 0.274 0.293
No 245 18 (7.3) 372 72 (19.4)
Yes 97 11 (11.3) 32 9 (28.2)
High cholesterol 0.693 0.940
No 314 26 (8.2) 328 66 (20.1)
Yes 28 3 (10.7) 76 17 (19.7)
Low HDL 0.246 0.002
No 247 18 (7.3) 156 20 (12.8)
Yes 95 11 (11.6) 248 61 (24.6)
Increased LDL 0.877 0.460
No 332 28 (8.4) 366 75 (20.5)
Yes 10 1 (10.0) 38 6 (15.8)
Increased triglyceridesc 0.606 0.044
No 271 24 (8.9) 325 58 (17.8)
Yes 71 5 (7.0) 79 23 (29.1)
Parental education level 0.005 0.049
Tertiary education 73 5 (6.8) 114 14 (12.3)
Secondary education 179 15 (8.4) 194 42 (21.6)
Primary/all age 32 8 (25.0) 54 14 (25.9)
Unknown 58 1 (1.7) 42 11 (26.2)
aP-values are from proportion post-estimation Wald tests. Adjustment for multiple testing was not performed as these were considered preliminary exploratory
analyses. If the Bonferroni correction for multiple testing were to be applied, the p-value for statistical significance would be 0.006.
bHigh glucose here is defined as upper quintile of glucose distribution.
cHigh triglyceride here is defined as upper quintile of triglyceride distribution.
hsCRP, high sensitivity C-reactive protein; BMI, body mass index; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol.
in the high risk hsCRP category having higher mean BMI and WC.
Among women, similar associations were seen for BMI and WC,
but additionally there were significant associations for systolic BP,
LDL, and triglycerides. Mean HDL was lower among women with
high risk hsCRP.
In order to evaluate the association between high hsCRP and
clustering of CVD risk factors, we computed a risk score based
on the number of metabolic syndrome components that a par-
ticipants had. We also evaluated the association between high
hsCRP and the metabolic syndrome. Results for these analyses
are shown in Figure 1 and Table S3 in Supplementary Material.
Approximately 39% of participants had one of the five risk factors,
14% two risk factors, and 0.8% of participants had the meta-
bolic syndrome. There was a statistically significant trend for
higher prevalence of high hsCRP as the number of risk factors
increased for both men and women (Figure 1). Mean and median
hsCRP increased with the number of risk factors with a statistically
significant test for trend (see Table S3 in Supplementary Material).
Results for the multiple logistic regression analyses, using high
hsCRP as the outcome are shown in Table 3. BMI and WC
were highly correlated (Pearson’s correlation coefficient, r = 0.81)
therefore we opted to use WC as the measure of adiposity in our
models. Model 1 assessed the relationship between high hsCRP
(outcome variable) and individual CVD risk factors and SES. Only
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FIGURE 1 | Proportion (%) of participants with high hsCRP based
on number of metabolic syndrome components for male and
female participants. The proportion of participants with high hsCRP
increased with the number of the metabolic syndrome components for
males (p=0.025), and for females (p<0.001). P -values were derived
from chi-squared tests. Tests for trend were also significant: p=0.011
for males; p<0.001 for females. hsCRP, high sensitivity C-reactive
protein.
central obesity and parental education remained statistically sig-
nificant correlates of hsCRP. Odds ratio for high hsCRP for those
with central obesity compared to those without was 7.8 (95% CI
4.8–12.9, p< 0.001). Participants whose highest parental educa-
tion level was in the primary/all-age category had a twofold higher
odds of high hsCRP compared to those with tertiary level parental
education (OR 2.47, 95% CI 1.17–5.20, p= 0.017). In the second
model, we examined whether the number of metabolic syndrome
components was associated with high hsCRP. After adjusting for
sex and parental education, having one component was associated
with a twofold increase in the odds of high hsCRP, while having
three or more components (i.e., having the metabolic syndrome)
was associated with a 14-fold increase in the odds of high hsCRP.
There was some evidence of sex interaction in the relationship
between hsCRP and education category (p= 0.049 for the inter-
action term for the “unknown” education category). We therefore
also present sex-specific estimates for these models in Table S4 in
Supplementary Material. The result from these models was gen-
erally similar to the un-stratified models, but estimates were less
precise with wide confidence intervals.
DISCUSSION
In this study among young adults in Jamaica, we found that
approximately 15% of participants had high risk hsCRP. High
hsCRP was more common among women and was strongly asso-
ciated with central obesity and the metabolic syndrome. There
was also a strong association between high hsCRP and cluster-
ing of CVD risk factors, with higher odds of high hsCRP as
the number of metabolic syndrome components increased. Addi-
tionally, there was a statistically significant trend for increasing
prevalence of high hsCRP as the number of metabolic syndrome
components increased. We also found that lower parental educa-
tion was associated with higher odds of high hsCRP particularly
among men.
The findings in this study are generally consistent with the
published literature. Among CVD risk factors, the strongest asso-
ciations appear to be with BMI and central obesity (31–34). In
one study among adults 25–60 years old in Burkino Faso, central
obesity was associated with a fourfold increase in the odds of high
hsCRP (>1 mg/L) while overweight status was associated with an
almost sevenfold increase in the odds in unadjusted models; how-
ever, in the fully adjusted model only central obesity and elevated
triglyceride was associated with log hsCRP (32). In another study
from China, while hsCRP showed significant correlations with all
the CVD risk factors studied the largest correlation coefficients
were seen for BMI and central obesity (31).
None of the other individual CVD risk factors studied were
retained in the final model as associations were no longer sig-
nificant after adjusting for confounding and model assessment
indicated that they did not improve the model. These findings are
consistent with results of the study from Burkino Faso and another
study from the Netherlands where only central obesity and ele-
vated triglyceride remained significant correlates of high hsCRP in
multivariable models (32, 33). The absence of an association with
elevated triglycerides in our study was probably due to the very low
prevalence of hypertriglyceridemia (0.5%) in this study. It should
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Table 3 | Final multivariable models for high hsCRP individual CVD risk factors and number of metabolic syndrome components.
Variable Odds ratioa 95% CI p-Valuea
MODEL 1 (HIGH hsCRPAND INDIVIDUAL CVD RISK FACTORS)
Central obesity (vs. no central obesity) 7.8 4.8–12.9 <0.001
Sex (male vs. female) 0.61 0.37–1.01 0.053
Parental education
Tertiary Reference category
Secondary 1.72 0.96–3.11 0.070
Primary/all age 2.47 1.17–5.20 0.017
Unknown 1.10 0.48–2.53 0.814
MODEL 2 (HIGH HSCRPAND NUMBER OF METABOLIC SYNDROME COMPONENTSb)
Number of metabolic syndrome components
None Reference category
One component 2.2 1.3–3.8 0.005
Two components 7.4 4.1–13.6 <0.001
Three or more components (i.e., having the metabolic syndrome) 13.5 2.4–76.0 0.003
Sex (male vs. female) 0.5 0.3–0.9 0.011
Parental education
Tertiary Reference category
Secondary 1.8 1.0–3.2 0.051
Primary/all age 2.8 1.3–5.7 0.006
Unknown 1.4 0.6–3.0 0.463
aOdds ratios and p-values were derived multivariable logistic model with high hsCRP as the outcome. Age was not significant and was therefore excluded from the
model. Significance level adjusted to 0.025 based on Bonferroni correction for two independent hypotheses tested in the study.
bRisk factors included are elevated blood pressure, high fasting glucose, central obesity, low HDL, and high triglycerides. hsCRP, high sensitivity C-reactive protein;
CVD, cardiovascular disease.
be noted, however, that one study from Korea, however, reported
a statistically significant inverse relationship between HDL and
hsCRP (35).
A number of studies also reported strong associations between
hsCRP and the number of CVD risk factors or metabolic syndrome
components (31–33, 36, 37). In one study analyzing National
Health and Nutrition Examination Survey (NHANES) 2009–10
data, participants with one metabolic syndrome component had a
twofold higher odds of high hsCRP while participants with all five
components had 11 times greater odds of high hsCRP (37). Being
classified as having the metabolic syndromes was also associated
with hsCRP level (16, 17, 31, 32). In the study from Burkino Faso,
participants with hsCRP >1 mg/L were twice as likely to have the
metabolic syndrome (32). Similarly, persons in the highest quar-
tile of hsCRP were seven times more likely to have the metabolic
syndrome compared to those in the lowest quartile (31).
We also found a significant inverse relationship between high
hsCRP and parental education level, with the association being
statistically significant for men whose highest parental education
level was primary or all age (up to grade 9) when compared to
those whose parents had tertiary level education. These findings
are consistent with a growing body of literature showing asso-
ciations between SES and hsCRP (13–15, 38–43). Most studies
show an inverse association with higher levels of hsCRP with
lower SES, with some studies showing significant sex-differences.
For example, in a report from the Coronary Artery Risk Devel-
opment in Young Adults (CARDIA) study, there were significant
associations between CRP for White men and women and for
Black women but not for Black men (42). Studies from Jamaica
have generally shown sex-differences in the relationship between
CVD and measures of SES (23, 44, 45). In a previous analysis from
this cohort maternal occupation at time of child’s birth was found
to be inversely related to BP, but was statistically significant in men
only (46). The relationship between hsCRP and SES suggest that
inflammation may be one of the mechanisms through which SES
influence CVD risk, but this requires further study. We acknowl-
edge that parental education as used here is a proxy for participants
SES; however, parental SES was used since the participants were
just entering into adulthood and at this age parental SES may be a
better measure of SES than their own SES.
Prevalence of high hsCRP in this study was approximately 15%.
There is little published data for this age group for comparison,
however, one study reported a prevalence of 13% for elevated
hsCRP (>3 mg/L) among 16-year-olds in Quebec, while another
study using data from NHANES 2009–10 found that 32% of the
US adult population had elevated hsCRP (19, 37). In another
analysis from NHANES 2009–10, an estimated 29% of US adults
20–29 years old had hsCRP ≥3 mg/L (47). The mean and median
hsCRP of our participants (1.5 and 0.7 mg/L, respectively) was
lower than that of the 20- to 29-year-olds of the NHANES database
3.5 and 1.4 mg/L, respectively) (47).
It has been recognized that preventing or delaying the onset
of the chronic non-communicable diseases is the goal of mod-
ern public health policy. To do this effectively requires early
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recognition of the occurrence of risk factors and taking action
to promote optimal health in light of evidence suggesting that
CVD risk factors tend to track from childhood into adulthood
(48, 49). In young adulthood, many of the traditional risk factors
are relatively uncommon and as such it may be difficult to predict
those at highest risk using only traditional risk factors. In this study,
while the prevalence of some individual risk factors was fairly high,
<1% was classified as having the metabolic syndrome. If we used
the metabolic syndrome as to classify participants with regards to
future CVD risk, the large majority of participants would be clas-
sified as being at lower than average risk of CVD. The prevalence
of high hsCRP, however, was approximately 15% suggesting that
the many persons classified as low risk based on the metabolic
syndrome criteria would be reclassified based on hsCRP. These
findings suggest that hsCRP may be useful marker of CVD risk
in young adults and may result in earlier identification of young
adults at high risk for CVD.
This study had some limitations. Firstly, we acknowledge that
there is significant short term variability hsCRP level, so mea-
surement of hsCRP on a single occasion may result in some
misclassification (5, 50). However, such misclassification is likely
to be non-differential; therefore, the true associations are likely
to be more extreme than reported. Additionally, there were miss-
ing data for some participants, while others had markedly ele-
vated hsCRP, which resulted in their exclusion from the analy-
ses. However, mean values for participant characteristics were
similar for included and excluded participants, suggesting that
this is unlikely to have influenced the findings of the study.
Additionally, the consistency of our findings with other stud-
ies suggests that our estimates are plausible. Finally, the cross-
sectional study design precludes any causal inferences from the
study.
The study also had some important strength. Few studies have
reported on hsCRP distribution among children, young adults,
and in populations outside of Europe and North America (8).
This has led to the Centers for Disease Control and American
Heart Association specifically calling for studies among the young,
the elderly, and within race/ethnic groups (8). This study was
conducted among Afro-Caribbean youth in a developing country
context and will be a valuable addition to the literature. Addition-
ally, the study is population based and therefore findings are likely
to be generalizable to urban Jamaica and to other populations with
similar age and race/ethnic composition.
We conclude that high hsCRP is strongly associated with central
obesity, the metabolic syndrome, and the number of cardiovascu-
lar risk factors. Our study suggests that hsCRP may improve CVD
risk assessment in young adults when compared to the metabolic
syndrome. Further longitudinal studies are needed to evaluate the
predictive value of hsCRP in young populations. Additionally, the
association between hsCRP and early markers of vascular health
such as pulse wave velocity should be evaluated.
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